Functional evaluation and clinical classification of BRCA2 variants
Nature,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 8, 2025
Germline
BRCA2
loss-of
function
variants,
which
can
be
identified
through
clinical
genetic
testing,
predispose
to
several
cancers1–5.
However,
variants
of
uncertain
significance
limit
the
utility
test
results.
Thus,
there
is
a
need
for
functional
characterization
and
classification
all
facilitate
management
individuals
with
these
variants.
Here
we
analysed
possible
single-nucleotide
from
exons
15
26
that
encode
DNA-binding
domain
hotspot
pathogenic
missense
To
enable
this,
used
saturation
genome
editing
CRISPR–Cas9-based
knock-in
endogenous
targeting
human
haploid
HAP1
cells6.
The
assay
was
calibrated
relative
nonsense
silent
validated
using
benign
standards
ClinVar
results
homology-directed
repair
assay7.
Variants
(6,959
out
6,960
evaluated)
were
assigned
seven
categories
pathogenicity
based
on
VarCall
Bayesian
model8.
Single-nucleotide
loss-of-function
associated
increased
risks
breast
cancer
ovarian
cancer.
integrated
into
models
ClinGen,
American
College
Medical
Genetics
Genomics,
Association
Molecular
Pathology9
Using
this
approach,
91%
classified
as
or
likely
benign.
These
improve
variant.
Results
comprehensive
evaluation
particularly
significance,
provide
useful
resource
who
carry
such
Language: Английский
Saturation mapping of MUTYH variant effects using DNA repair reporters
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 6, 2025
Variants
of
uncertain
significance
(VUS)
limit
the
actionability
genetic
testing.
A
prominent
example
is
MUTYH
,
a
base
excision
repair
factor
associated
with
polyposis
and
colorectal
cancer,
which
has
pathogenic
variant
carrier
rate
approaching
1
in
50
individuals
some
populations.
To
systematically
interrogate
function
we
coupled
deep
mutational
scanning
DNA
reporter
containing
its
lesion
substrate,
8OG:A.
Our
variant-to-function
map
covers
>97%
all
possible
point
variants
(n=10,941)
achieves
100%
accuracy
classifying
pathogenicity
known
clinical
(n=247).
Leveraging
large
registry,
observe
significant
associations
polyps
more
severely
impaired
missense
conferring
greater
risk.
We
recapitulate
functional
differences
between
founder
alleles,
highlight
sites
complete
intolerance,
including
residues
that
intercalate
coordinate
essential
Zn
2+
or
Fe-S
clusters.
This
provides
resource
to
resolve
1,032
existing
VUS
90
conflicting
interpretations
demonstrates
scalable
strategy
other
clinically
relevant
factors.
Language: Английский